Evidence map›Paper›PMID 34071730›Full record

ArticleToxins2021

Characterization and Pharmacological Inhibition of the Pore-Forming

Katharina Ernst, Marc Landenberger, Julian Nieland, Katharina Nørgaard, Manfred Frick, Giorgio Fois, Roland Benz, Holger Barth

Open access · goldAbstract read
In one paragraph

Article in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Veterinary sciences · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Open forum infectious diseases · 2023
    Article
  10. CDT ofToxins · 2023
    Article
  11. Article
  12. An Update onToxins · 2022
    Review
  13. The Pore-Forming Subunit C2IIa of the BinaryFrontiers in pharmacology · 2022
    Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Katharina ErnstInstitute of Pharmacology and Toxicology, Ulm University Medical Center, 89081 Ulm, Germany.
Marc LandenbergerInstitute of Pharmacology and Toxicology, Ulm University Medical Center, 89081 Ulm, Germany.
Julian NielandInstitute of Pharmacology and Toxicology, Ulm University Medical Center, 89081 Ulm, Germany.
Katharina NørgaardInstitute of Pharmacology and Toxicology, Ulm University Medical Center, 89081 Ulm, Germany.
Manfred FrickInstitute of General Physiology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0002-4763-1104
Giorgio FoisInstitute of General Physiology, Ulm University, 89081 Ulm, Germany.ORCID 0000-0001-5414-1149
Roland BenzDepartment of Life Sciences and Chemistry, Jacobs-University Bremen, 28759 Bremen, Germany.ORCID 0000-0002-9510-9265
Holger BarthInstitute of Pharmacology and Toxicology, Ulm University Medical Center, 89081 Ulm, Germany.
Universität Ulm · DEConstructor University · DE

Funding

Deutsche Forschungsgemeinschaft BA2087/2-2 to HBDeutsche Forschungsgemeinschaft CRC 1149 (A05)-Project number 251293561-SFB 1149European Social Fund and Ministry of Science, Research and Art Baden-Württemberg Margarete von Wrangell Habilitation program to KEMedical Faculty Ulm Promotionsprogramm Experimentelle Medizin to ML and KN
6 · The paper itself

Abstract

The clinically highly relevant

Indexed as

ActinsAnimalsBacterial ToxinsCaco-2 CellsCalciumCell SurvivalChlorocebus aethiopsChloroquineClostridioides difficileHumansVero CellsActinsBacterial ToxinsCalciumChloroquinebacterial binary AB-toxinsCDT toxinchloroquineClostridioides difficilepore blockerpore-forming toxinstransmembrane pore

Identifiers

PMID34071730
PMCPMC8226936
OpenAlexW3165084404

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.